Literature DB >> 22392349

Relationship between CDT and disease activity in rheumatoid arthritis.

B Cylwik1, A Chludzinska, L Chrostek, E Gruszewska, E Gindzienska-Sieskiewicz, M Szmitkowski, S Sierakowski.   

Abstract

The aim of this study was to estimate the serum concentration of carbohydrate-deficient transferrin (CDT) in patients with rheumatoid arthritis (RA) and the relationship between the CDT level and disease activity in RA patients. Studies were carried out in 47 female patients with RA and 32 healthy women. Disease activity of RA was evaluated using the 28-joint count Disease Activity Score (DAS 28). Serum CDT was determined by particle-enhanced immunononephelometry using the N Latex CDT test. Patients with RA had significantly lower serum concentrations of CDT compared with controls. The correlation study showed the significant negative relationship between CDT and DAS 28 (r = - 0.483, p = 0.011). There were no correlations between serum CDT level and patient's age, disease duration, number of tender and swollen joints, and degree of disability evaluated by the Health Assessment Questionnaire. The level of CDT in patients with RA was significantly decreased and confirms the changes in transferrin glycosylation which are dependent on the disease activity. Therefore, measurement of CDT in the sera of patients with RA can be useful for the evaluation of disease activity in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392349     DOI: 10.1007/s00393-011-0853-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

1.  Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.

Authors:  M Watson; P M Rudd; M Bland; R A Dwek; J S Axford
Journal:  Arthritis Rheum       Date:  1999-08

2.  Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

Authors:  D M van der Heijde; M A van 't Hof; P L van Riel; L A Theunisse; E W Lubberts; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis.

Authors:  Ewa Gindzienska-Sieskiewicz; Piotr Adrian Klimiuk; Dariusz Gabriel Kisiel; Andrzej Gindzienski; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2006-08-04       Impact factor: 2.980

4.  Association of self-reported diseases and health care use with commonly used laboratory markers for alcohol consumption.

Authors:  P Sillanaukee; N Strid; P Jousilahti; E Vartiainen; K Poikolainen; S Nikkari; J P Allen; H Alho
Journal:  Alcohol Alcohol       Date:  2001 Jul-Aug       Impact factor: 2.826

Review 5.  Possible reasons why heavy drinking increases carbohydrate-deficient transferrin.

Authors:  P Sillanaukee; N Strid; J P Allen; R Z Litten
Journal:  Alcohol Clin Exp Res       Date:  2001-01       Impact factor: 3.455

Review 6.  Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation.

Authors:  T Arndt
Journal:  Clin Chem       Date:  2001-01       Impact factor: 8.327

7.  Serum carbohydrate-deficient transferrin: mechanism of increase after chronic alcohol intake.

Authors:  Y Xin; J M Lasker; C S Lieber
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

Review 8.  Quantitation of the oligosaccharides of human serum IgG from patients with rheumatoid arthritis: a critical evaluation of different methods.

Authors:  F H Routier; E F Hounsell; P M Rudd; N Takahashi; A Bond; F C Hay; A Alavi; J S Axford; R Jefferis
Journal:  J Immunol Methods       Date:  1998-04-15       Impact factor: 2.303

9.  Transferrin microheterogeneity in rheumatoid arthritis. Relation with disease activity and anemia of chronic disease.

Authors:  R A Feelders; G Vreugdenhil; G de Jong; A J Swaak; H G van Eijk
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.